The loss of Ionis Pharmaceuticals under GAAP for 6 months of 2020 amounted to $102 million, compared to profit $81 million in the previous year. Revenues decreased by 39.5% to $279 million compared to $461 million a year earlier.
The loss of Ionis Pharmaceuticals under GAAP for 6 months of 2020 amounted to $102 million, compared to profit $81 million in the previous year. Revenues decreased by 39.5% to $279 million compared to $461 million a year earlier. 
ir.ionispharma.com
English (US) 